High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies

Magnetic Resonance Materials in Physics, Biology and Medicine

Volumn 21, Issue 6, 2008, Pages 435-442

  Van Asten, Jack J A ^a   Cuijpers, Vincent ^a   Hulsbergen Van De Kaa, Christina ^a   Soede Huijbregts, Claudia ^a   Witjes, J Alfred ^a   Verhofstad, Albert ^a   Heerschap, Arend ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gleason score; HRMAS NMR spectroscopy; Prostate cancer; Prostate needle biopsy

Indexed keywords

CHOLINE; CITRIC ACID; LACTIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; COMPARATIVE STUDY; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTON NUCLEAR MAGNETIC RESONANCE;

BIOPSY, NEEDLE; CHOLINE; CREATININE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 57449113368     PISSN: 09685243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10334-008-0156-9     Document Type: Article

References (39)

1. JR Thornbury DK Ornstein PL Choyke CP Langlotz JC Weinreb 2001 Prostate cancer: what is the future role for imaging AJR Am J Roentgenol 176 17 22
2. X Gao AT Porter DJ Grignon JE Pontes KV Honn 1997 Diagnostic and prognostic markers for human prostate cancer Prostate 31 264 281
3. Deshmukh N, Foster CS (2002) Grading prostate cancer. In: Foster CS, Bostwick DG(eds) Pathology of the prostate. W.B. Saunders Company, Philadelphia, pp 191-227
4. Matsumoto T, Mochida O, Kumazawa J, Kinjo M, Sagiyama K (2002) Critical assessment of inflammatory lesions of the prostate, including cytopathologic appearances and diagnosis. In: Foster CS, Bostwick DG(eds) Pathology of the prostate. W.B. Saunders Company, Philadelphia, pp 56-65
5. JC Nickel LD True JN Krieger RE Berger AH Boag ID Young 2001 Consensus development of a histopathological classification system for chronic prostatic inflammation BJU Int 87 797 805
6. Helpap B (2002) Benign prostatic hyperplasia. In: Foster CS, Bostwick DG(eds) Pathology of the Prostate. W.B. Saunders Company, Philadelphia, pp 66-113
7. 1H-spectroscopy of the human prostate: benign prostaic hyperplasia, normal peripheral zone and adenocarcinoma Magn Reson Med 29 285 291
8. 31P magnetic resonance spectroscopy J Urol 150 2019 2024
9. 1H magnetic resonance spectroscopy and biochemical study Magn Reson Med 29 149 157
10. 1H magnetic resonance spectra Cancer Res 57 3398 3401
11. M van der Graaf R Schipper G Oosterhof J Schalken A Verhofstad A Heerschap 2000 Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer MAGMA 10 153 159
12. AM Tomlins PJD Foxall JC Lindon MJ Lynch M Spraul JR Everett JK Nicholson 1998 High resolution magic angle spinning H-1 nuclear magnetic resonance analysis of intact prostatic hyperplastic and tumour tissues Anal Commun 35 113 115
13. 1H NMR spectroscopy at 9.4 T FEBS Lett 494 112 116
14. 1H HR-MAS investigations of four potential markers for prostate cancer Proc Int Soc Mag Reson 9 2336
15. 1H NMR in solid-phase organic synthesis J Org Chem 59 7955 7956
16. 1H NMR of tissue biopsies Biochem Cell Biol 76 472 476
17. D Huhn Stephen M Szabo Christina H Gass Jerome E Manzi Adriana 2004 Metabolic profiling of normal and hypertensive rat kidney tissues by hrMAS-NMR spectroscopy Anal Bioanal Chem 378 1511 1519
18. S Meiboom D Gill 1958 Modified Spin-echo Method for measuring nuclear relaxation times Rev Sci Instrum 29 688 691
19. Bancroft JD, Stevens A, Turner DR (1996) Theory and practice of histopathological techniques. Churchill Livingstone, New York, p 101
20. GM Swanson DB Vigneron ZL Tabatabai RG Males L Schmitt PR Carroll JK James RE Hurd J Kurhanewicz 2003 Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues Magn Reson Med 50 944 954
21. 1H HR-MAS spectroscopy Magn Reson Med 55 1257 1264
22. CL Wu JL Taylor W He AG Zepeda EF Halpern A Bielecki RG Gonzalez LL Cheng 2003 Proton high-resolution magic angle spinning NMR analysis of fresh and previously frozen tissue of human prostate Magn Reson Med 50 1307 1311
23. 1H NMR spectroscopy in organs and tissues using slow Magic Angle Spinning Magn Reson Med 46 213 218
24. JL Taylor CL Wu D Cory RG Gonzalez A Bielecki LL Cheng 2003 High-Resolution Magic Angle Spinning Proton NMR Analysis of Human Prostate Tissue With Slow Spinning Rates Magn Reson Med 50 627 632
25. J Kurhanewicz DB Vigneron SJ Nelson H Hricak JM MacDonald B Konety P Narayan 1995 Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy Urology 45 459 466
26. A Heerschap GJ Jager M van der Graaf JO Barentsz JJMCH de la Rosette GON Oosterhof ETG Ruijter SHJ Ruijs 1997 In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue Anticancer Res 17 1455 1460
27. J Kurhanewicz DB Vigneron RG Males MG Swanson KK Yu H Hricak 2000 The prostate: MR imaging and spectroscopy. Present and future Radiol Clin North Am 38 115 138
28. N Shah A Sattar M Benanti S Hollander L Cheuck 2006 Magnetic resonance spectroscopy as an imaging tool for cancer: a review of the literature J Am Osteopath Assoc 106 1 23 7
29. JJ Futterer TW Scheenen SW Heijmink HJ Huisman CA Hulsbergen-Vande Kaa JA Witjes A Heerschap JO Barentsz 2007 Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate Invest Radiol 42 2 116 122
30. MJ Lynch JK Nicholson 1997 Proton MRS of human prostatic fluid: correlations between citrate, spermine, and myo-inositol levels and changes with disease Prostate 30 248 255
31. LC Costello RB Franklin 2006 The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots Mol Cancer 5 17
32. J-w Kim CV Dang 2006 Cancer's molecular sweet tooth and the Warburg effect Cancer Res 66 8927 8930
33. K Golman R In't Zandt M Thaning 2006 Real-time metabolic imaging Proc Natl Acad Sci USA 103 30 11270 11275
34. Stoyanova R, Swanson MG, Vigneron DB, Kurhanewicz J, Brown TR (2002) Metabolite Profiles Associated with Prostate Tissue Subcomponents, Proc Intl Soc Mag Reson Med, 10
35. KL Zakian 2005 Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy Radiology 234 3 804 814
36. Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB (2002) Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 16(4):451-463. Review
37. Podo F (1999) Tumour phospholipid metabolism. NMR Biomed 12(7):413-439. Review
38. K Glunde MA Jacobs ZM Bhujwalla 2006 Choline metabolism in cancer: implications for diagnosis and therapy Expert Rev Mol Diagn 6 6 821 829
39. LL Cheng MA Burns JL Taylor W He EF Halpern WS McDougal CL Wu 2005 Metabolic Characterization of Human Prostate Cancer with Tissue Magnetic Resonance Spectroscopy Cancer Res 65 3030 3035